AbSci(ABSI)
$10.12+0.15 (+1.50%)
ABSI
AbSci stock drug pipeline
$10.12
At close:+0.15 (+1.50%)
Want to see ABSI full AI Analyst Report?
AbSci (ABSI) Drug Pipeline
1,365 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Abs-201 Iv Single Dose, Abs-201 Sc Multiple Doses | Healthy Volunteers - Male And Female, Androgenetic Alopecia (Aga) | phase1AndPhase2 | Recruiting | Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia | Nov 19, 2025 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Abs-201 Iv Single Dose, Abs-201 Sc Multiple Doses | phase1AndPhase2 | Healthy Volunteers - Male And Female, Androgenetic Alopecia (Aga) | Recruiting | Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia | Nov 19, 2025 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Absci Corp. (ABSI) have in its pipeline
AbSci ABSI is currently developing the following drugs: Abs-201 Iv Single Dose, Abs-201 Sc Multiple Doses. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
